Print Page   |   Sign In   |   Join Now!
News & Press: Legislative & Regulatory

Pharmacy Alert

Wednesday, November 5, 2014   (0 Comments)
Posted by: Tijonne Edmond
Share |

The following has been released by the Louisiana Board of Pharmacy.

 

The Louisiana State Board of Medical Examiners (LSBME) has advised our office of action(s) taken with respect to the following practitioner(s), the effect of which has altered their legal authority to order or prescribe medications and/or devices for Louisiana residents.  Following the name will be the credential number(s) in brackets; the date in parentheses is the effective date of the action taken by the LSBME.

  • Mark Alan Parent [MD.017736 / CDS.015811-MD / DEA - FP3339264](09-15-2014)  Our records indicate Dr. Parent has practiced medicine in several areas around the state, including Denham Springs, Jennings, and Prairieville.  SBME has placed his medical license on probation for 5 years, subject to certain terms enumerated in their order.  Among other terms, he has no personal privileges for Schedule II; however, he may prescribe or order other controlled substances listed in Schedules III, IV, or V.  Alternative privileges are in place for patients in hospitals.  Further, he shal notl prescribe any controlled substances for the treatment of non-cancer related chronic pain or obesity.


Alternative privileges
:  In the event the prescriber intends to treat inpatients at a hospital or other similar facility, the prescriber may order any controlled substances (in any schedule) or other medication for administration to such inpatients, but only under the authority of that facility's DEA registration number and in accordance with that facility's policies and procedures.  For those pharmacists practicing in such hospitals or facilities, you should be aware the facility is responsible for assigning a unique suffix number for each prescriber it has authorized to practice under its facility registration.  Further, pharmacists recording controlled substance dispensing authorized by such prescribers are required to note the suffixed DEA registration number, not the prescriber's personal DEA registration number.

In the event you have any questions or need additional information about the actions taken by the LSBME, you should contact their office at 504.568.6820 or lsbme@lsbme.la.gov.

 


Copyright © 2010 Louisiana Pharmacists Association. All Rights Reserved.
620 Florida St., Suite 210 | Baton Rouge, LA 70801 | (225) 346-6883 | Fax (225) 344-1132

Association Management Software Powered by YourMembership  ::  Legal